Ads
related to: squamous cell carcinoma cancer- Learn About Treatment
Visit the patient website today
to learn about a treatment option.
- Patient Examples
Patient examples from
clinical trials.
- Patient Education
Get Information to Help Answer
Your Questions About Advanced CSCC.
- Patient Testimonials
Watch Videos And Hear From Real
Advanced CSCC Patients.
- Patient Study Results
See Clinical Trial Results And
Learn About A Treatment Option.
- Patient Support
Find helpful resources and get
answers about a treatment option.
- Learn About Treatment
Search results
Study Finds Radiotherapy for NMSC in Dermatology Growing
Medscape· 6 days agoMore specifically, the persistent growth in the use of superficial radiotherapy (SRT) devices and...
ASCO: Early peek at Merus' bispecific cancer data lives up to investors' expectations
FierceBiotech· 3 days agoAnalysts have hailed Merus’ latest data drop in head and neck cancer as meeting investors’...
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 3 days agoKeytruda (pembrolizumab) is Merck & Co Inc’s (NYSE:MRK) top selling cancer drug. The abstract...
Chemoradiotherapy or RT in Lower Risk Early Cervical Cancer?
Medscape· 5 days agoA study found no significant differences in survival with postoperative chemoradiotherapy vs RT...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive new results from an ongoing Phase 1/2 trial evaluating its first-in-class costimulatory bispecific antibody, REGN7075 ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 4 days agoHOOKIPA to present an oral abstract at the American Society for Clinical Oncology (ASCO) 2024 Annual Meeting on June 4Updated data of HB-200 plus pembrolizumab demonstrate a favorable safety profile and promising clinical activity In a subset
Rutgers Cancer Institute and RWJBarnabas Health Set to Unveil Extensive, New Cancer Research...
Benzinga· 4 days ago49 scheduled presentations will explore several types of cancer, as well as the next frontier of health equity NEW BRUNSWICK, N.J., May 23, 2024 /PRNewswire/ -- Clinicians ...
These Are The Expert-Approved Ways To Help Prevent Skin Cancer | Essence
Essence· 6 days agoBy now, we know our melanin doesn’t protect us from the sun, thanks to hyperpigmentation, premature...
Mabwell Announces 9MW2821 Clinical Data and Latest Progress to be presented at 2024 ASCO Annual...
FOX 59 Indianapolis· 3 days agoMabwell (688062.SH), an innovation-driven biopharmaceutical company, announced the data and latest...
Galectin Therapeutics (NASDAQ:GALT) Stock Price Passes Above Two Hundred Day Moving Average of $2.25
ETF DAILY NEWS· 6 days agoGalectin Therapeutics Inc. (NASDAQ:GALT – Get Free Report)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.25 and ...